Paris, France – July 31, 2015 – Sanofi (EURONEXT : SAN ; NYSE : SNY) announces that its half-year financial report for the period ending June 30, 2015 is now available and has been filed with the French market regulator Autorité des marchés financiers (AMF) and submitted to the U.S. Securities and Exchange Commission (SEC) under form 6-K.
This document may be found on the company’s corporate website: www.sanofi.com and down loaded from the “Investors” page under the heading “Regulated Information in France.”
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
|Media Relations||Investor Relations|
|Laurence Bollack||Sébastien Martel|
|Tel.:+33 (0) 1 53 77 46 46||Tel.: +33 (0) 1 53 77 45 45|